›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:Blueprint Genetics Comprehensive Hereditary Cancer Panel
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Quest DiagnosticsType:
Laboratory Developed Test
Related tests:
Blueprint Genetics Comprehensive Hereditary Cancer Panel is a 160 gene panel that includes assessment of non-coding variants. It is ideal for patients with a clinical suspicion of inherited susceptibility to cancer. This panel is designed to detect heritable germline mutations and should not be used for the detection of somatic mutations in tumor tissue.
Gene:
ALK (Anaplastic lymphoma kinase), ATM (ATM serine/threonine kinase), BAP1 (BRCA1 Associated Protein 1), BARD1 (BRCA1 Associated RING Domain 1), BRAF (B-raf proto-oncogene), BRCA1 (Breast cancer 1, early onset)
See More ...
ALK (Anaplastic lymphoma kinase), ATM (ATM serine/threonine kinase), BAP1 (BRCA1 Associated Protein 1), BARD1 (BRCA1 Associated RING Domain 1), BRAF (B-raf proto-oncogene), BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset), BRIP1 (BRCA1 Interacting Protein C-terminal Helicase 1), CDH1 (Cadherin 1), CDKN1B (Cyclin dependent kinase inhibitor 1B), CDKN1C (Cyclin Dependent Kinase Inhibitor 1C), CDKN2A (Cyclin Dependent Kinase Inhibitor 2A), CEBPA (CCAAT Enhancer Binding Protein Alpha), EGFR (Epidermal growth factor receptor), FANCA (FA Complementation Group A), FANCB (FA Complementation Group B), FANCC (FA Complementation Group C), MET (MET proto-oncogene, receptor tyrosine kinase), NRAS (Neuroblastoma RAS viral oncogene homolog), PALB2 (Partner and localizer of BRCA2), POLE (DNA Polymerase Epsilon), RAD51C (RAD51 paralog C), RAD51D (RAD51 paralog D), RET (Ret Proto-Oncogene), SMAD4 (SMAD family member 4), SMARCA4 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A, member 4), TP53 (Tumor protein P53)
